Delivery Order SPE2DB22D1106-SPE2DB25FDWX3

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.62 firm fixed-price delivery order contract is for the supply of hydrocodone-acetaminophen 10-325 mg tablets in 100-count bottles. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is a delivery order valued at $1,759.35 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,564,529,180 units of the drug hydrocodone-acetaminophen 7.5-325 mg, a pain medication, with a performance period through May 8, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,058.80 firm fixed-price delivery order is for the supply of hydrocodone-acetaminophen 7.5-325 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of 4,564,590,394 units of the pharmaceutical product Hydrocodone-Acetaminophen 7.5-325/15 473ML to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $1,036.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2024. It was awarded on May 13, 2024, and is...
This federal contract award, valued at $2,109.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565332615 - HYDROCODONE-ACETAMIN 10-325 MG 100S. The contract is a Delivery Order awarded under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for supplying a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,150.88 and is a delivery order placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC is valued at $999,999,999 and runs through November 2026, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,677.16, is for the delivery of hydrocodone-acetaminophen 7.5-325 mg tablets in 100-count bottles. This is a firm-fixed-price delivery order contract with a completion date of January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of HYDROCODONE-ACETAMIN 10-325 MG 100S pharmaceutical products to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major distributor of pharmaceutical and medical supplies to federal agencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,565.06 Firm Fixed Price Delivery Order is for the supply of 4,565,032,883 units of the prescription drug hydrocodone-acetaminophen 10-325 mg, with a delivery deadline of July 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.90 firm fixed-price delivery order is for the supply of HYDROCODONE/ACETAMINOPHEN LIQ, a pain medication. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDWX3
    Delivery Order

This federal contract award, valued at $1,154.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,116,749 units of hydrocodone-acetaminophen 10-325 mg tablets. This contract represents a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was an open competition.

Generated 5/2/25, 10:13 AM